{
    "Trade/Device Name(s)": [
        "FastPack IP Sex Hormone Binding Globulin Immunoassay",
        "FastPack IP SHBG"
    ],
    "Submitter Information": "Qualigen, Inc.",
    "510(k) Number": "K182521",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083867"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "January 29, 2019",
    "Summary Letter Received Date": "December 26, 2018",
    "Submission Date": "December 20, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Sex Hormone Binding Globulin (SHBG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium-heparin tube",
        "Serum tube"
    ],
    "Instrument(s)/Platform(s)": [
        "FastPack System",
        "FastPack Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for FastPack IP Sex Hormone Binding Globulin Immunoassay for quantitative measurement of SHBG in serum and plasma.",
    "Indications for Use Summary": "A chemiluminescent immunoassay intended for the quantitative determination of Sex Hormone Binding Globulin in human serum and plasma on the FastPack System, as an aid in the diagnosis of androgen disorders.",
    "fda_folder": "Clinical Chemistry"
}